Free Submission Public Relations &
Deutsch English


Recently released market study: Genzyme Corporation - SWOT, Strategy and Corporate Finance Report

Print article Print article
2013-12-08 04:24:19 - Fast Market Research recommends "Genzyme Corporation - SWOT, Strategy and Corporate Finance Report" from MarketLine, now available

Genzyme Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.


* Detailed information on Genzyme Corporation required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Genzyme Corporation in the form of a SWOT analysis
* An in-depth view of the business model of Genzyme Corporation including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Genzyme Corporation

Intelligence on Genzyme Corporationnv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Genzyme Corporation, such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- ..


Genzyme (or 'the company'), a Sanofi company, is one of the world's leading biotechnology companies. The company offers medicines for rare inherited disorders, kidney diseases, orthopaedics, cancer, and transplant and immune disease. Genzyme primarily operates in the Americas and Europe. It is headquartered in Cambridge, Massachusetts. Sanofi, a France-based global Big Pharma company, completed the acquisition of Genzyme for a total of $20.1 billion plus a contingent value right, in April 2011. As a result, Genzyme now operates as a wholly-owned subsidiary of Sanofi. Genzyme* recorded net sales of $1,785 million during the financial year ended December 2012 (FY2012), an increase of 59.1% over FY2011. *Sanofi, the parent company of Genzyme, has disclosed Genzyme's revenues under 'New Genzyme', for the financial year ended December 31, 2012. It started recognizing net sales of Genzyme products from April 01, 2011.

Reasons to Purchase:

* Gain understanding of Genzyme Corporation and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Genzyme Corporation as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Genzyme Corporation's business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Genzyme Corporation: Company Overview
Genzyme Corporation: Overview and Key Facts
Genzyme Corporation: Overview
Genzyme Corporation: Key Facts
Genzyme Corporation: Key Employees
Genzyme Corporation: Key Employee Biographies
Genzyme Corporation: Major Products and Services
Genzyme Corporation: Company History
Genzyme Corporation: Management Statement
Genzyme Corporation: Locations and Subsidiaries
Genzyme Corporation: Key Competitors
Genzyme Corporation: Company Analysis
Genzyme Corporation: Business Description
Genzyme Corporation: SWOT Analysis
Genzyme Corporation: SWOT Overview
Genzyme Corporation: Strengths
Genzyme Corporation: Weaknesses
Genzyme Corporation: Opportunities
Genzyme Corporation: Threats
Genzyme Corporation: Corporate Financial Deals Activity
Genzyme Corporation: Financial Deals Overview
Genzyme Corporation: Targets and Partners
Genzyme Corporation: Top Deals 2009 - 2013YTD*
Genzyme Corporation: Advisors
Genzyme Corporation: Top Legal Advisors
Genzyme Corporation: Top Financial Advisors
Genzyme Corporation: Mergers and Acquisitions
Genzyme Corporation: Corporate Venturing
Genzyme Corporation: Capital Raising
Genzyme Corporation: Partnership
Genzyme Corporation: Divestments
Genzyme Corporation: Private Equity and Ownership
Genzyme Corporation: Recent Developments
Genzyme Corporation: News and Events Summary
Genzyme Corporation: Business Expansion
Genzyme Corporation: Corporate Governance
Genzyme Corporation: Financial Deals
Genzyme Corporation: Financial Performance
Genzyme Corporation: Regulatory and Legal Events
Genzyme Corporation: Research & Development
Genzyme Corporation: Strategy and Operations
Contact Us
About Datamonitor

List of Tables

Table 1: Genzyme Corporation: Key Facts
Table 2: Genzyme Corporation: Key Employees
Table 4: Genzyme Corporation: Key Competitors
Table 5: Genzyme Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Genzyme Corporation: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 7: Genzyme Corporation: M&A Average Deal Size - Value (US$m)
Table 8: Genzyme Corporation: Targets and Partners
Table 9: Genzyme Corporation: Top Deals 2009 - 2013YTD*
Table 10: Genzyme Corporation: Legal Advisor Ranking by Value (US$m)
Table 11: Genzyme Corporation: Financial Advisor Ranking by Value (US$m)
Table 12: Genzyme Corporation: M&A Volume and Value Trend (2009 - YTD*2013)
Table 13: Genzyme Corporation: M&A Activity by Geography (2009 - YTD*2013)
Table 14: Genzyme Corporation: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 15: Genzyme Corporation: Corporate Venturing by Geography (2009 - YTD*2013)
Table 16: Genzyme Corporation: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 17: Genzyme Corporation: Capital Raising by Deal Type (2009 - YTD*2013)
Table 18: Genzyme Corporation: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 19: Genzyme Corporation: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 20: Genzyme Corporation: Divestments by Geography (2009 - YTD*2013)

Full Table of Contents is available at:

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact